These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 17511723

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Practice patterns in screening and management of prostate cancer in elderly men.
    Konety BR, Sharp VJ, Verma M, Williams RD, Iowa Prostate Cancer Consensus Panel.
    Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
    [Abstract] [Full Text] [Related]

  • 5. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M, Eddy B, Poulsen J.
    Scand J Urol Nephrol; 2005 Nov; 39(3):214-8. PubMed ID: 16118092
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM, Hollenbeck BK, Daignault S, Kim SP, Wei JT.
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients].
    Costa P, Ben Naoum K, Boukaram M, Wagner L, Louis JF.
    Prog Urol; 2004 Feb; 14(1):33-9. PubMed ID: 15098749
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
    Paick JS, Kim SW, Ku JH.
    Yonsei Med J; 2007 Apr 30; 48(2):281-8. PubMed ID: 17461528
    [Abstract] [Full Text] [Related]

  • 15. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer.
    Barry MJ, Fowler FJ, Bin L, Oesterling JE.
    J Urol; 1997 Aug 30; 158(2):488-91; discussion 492. PubMed ID: 9224330
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
    Seftel AD, Rosen RC, Rosenberg MT, Sadovsky R.
    Int J Clin Pract; 2008 Apr 30; 62(4):614-22. PubMed ID: 18266709
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS, Goel V, Williams JI, Iscoe NA.
    CMAJ; 1999 Jan 12; 160(1):70-5. PubMed ID: 9934349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.